+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Prescription Delivery Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2027-2032)

  • PDF Icon

    Report

  • 140 Pages
  • November 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6294917
The prescription delivery services market size is expected to grow from USD 13.06 billion in 2026 to USD 14.48 billion in 2027 and is forecast to reach USD 24.27 billion by 2032 at 10.88% CAGR over 2027-2032. This report is Segmented by Service Model (Mail-Order Pharmacy Services and More), Delivery Mode (Standard Postal Delivery and More), Medication Type (Chronic Disease Medication and More), Prescription Type (New Prescriptions and More), End User (Individual Patient and More), Channel (Pharmacy-Owned Channel and More), and Geography (North America, Europe, and More). Market Forecasts are in Value (USD).

Global Prescription Delivery Services Market Trends and Insights

Chronic-Disease Refill Density and Longer-Day-Supply Prescriptions

Patients managing hypertension, diabetes, and cardiovascular disease generate recurring prescription demand that supports home delivery operations. Home delivery services improved medication adherence among patients with diabetes, hypertension, and high cholesterol by 17.2%, 18.6%, and 16.1%, respectively. Patients receiving 90-day prescriptions through home delivery experienced up to 38% fewer instances of nonadherence than retail pharmacy users. Higher adoption of home delivery for maintenance medications could generate substantial savings for U.S. consumers and employers. Extended-day supplies also reduce fulfillment costs by lowering shipment frequency per patient.

Telemedicine-to-Pharmacy Prescription Conversion

Telehealth is emerging as a direct channel for prescription generation and fulfillment in the prescription delivery services market. Virtual care providers can connect patients with delivery-focused pharmacies without requiring a separate retail pharmacy visit. Integrated platforms provide prescribers with inventory and pricing information during virtual consultations, reducing the risk of unfilled prescriptions following digital appointments. This model is particularly relevant for weight-management care, where immediate medication decisions and delivery options can support treatment initiation. It also encourages digital health platforms to develop closer pharmacy partnerships.

Cold-Chain and Temperature-Excursion Liability

GLP-1 therapies, biologics, and specialty injectables require stringent temperature control throughout delivery. Many cold-chain medicines must remain between 2°C and 8°C during shipment and handoff. Temperature excursions can render medicines unusable, requiring replacement and creating financial and clinical risks for pharmacies and logistics providers. Loading delays, route changes, and failed handoffs present the highest risks. In South Asia and Southeast Asia, high temperatures and inconsistent logistics infrastructure further complicate last-mile temperature control, requiring validated packaging, clear handoff procedures, and real-time tracking.

Other drivers and restraints analyzed in the detailed report include:

  1. Specialty and High-Value Medication Home Fulfillment
  2. Access, Automated Refills, and Same-Day Infrastructure
  3. Last-Mile Economics for Low-Density and Failed-Delivery Addresses

Segment Analysis

Mail-order pharmacy services held 45.45% of the prescription delivery services market in 2026, supported by established PBM programs that route 90-day maintenance prescriptions to centralized pharmacies. This model provides predictable demand and operational efficiencies. Retail pharmacy home delivery is also expanding as store-based chains add local courier services, although profitability remains challenging in low-density areas.

Digital pharmacy fulfillment is forecast to grow at an 11.55% CAGR through 2032, integrating prescribing, payment, dispensing, and delivery. Shared automated fulfillment can reduce capital requirements for retailers, grocery chains, and health systems. Hospital and specialty pharmacy delivery remains essential for restricted-distribution therapies, while telepharmacy-enabled dispensing is expanding in Asia-Pacific. Thailand’s Food and Drug Administration certified LINE MAN as a telepharmacy platform in June 2026.

Standard postal delivery held 51.45% of the prescription delivery services market share in 2026. It remains cost-effective for stable 90-day maintenance prescriptions that do not require immediate delivery. The model supports high shipment volumes, planned routes, and lower distribution costs. Pickup-enabled hybrid services also provide patients with greater flexibility over collection times.

Next-day delivery is projected to grow at a 13.46% CAGR through 2032, driven by temperature-sensitive biologics, GLP-1 medicines, and acute prescriptions. Amazon Pharmacy stated that it was making three-hour prescription delivery available in more than 350 U.S. cities in 2026. Same-day delivery supports urgent prescriptions, while traceability requirements under the Drug Supply Chain Security Act increase the need for integrated dispensing and delivery records.

Complete Report Scope:

  • By Service Model
    • Mail-Order Pharmacy Services
    • Retail Pharmacy Home Delivery
    • Digital Pharmacy Fulfillment
    • Hospital and Specialty Pharmacy Delivery
    • Telepharmacy-Enabled Home Dispensing
  • By Delivery Mode
    • Standard Postal Delivery
    • Next-Day Delivery
    • Same-Day Delivery
    • Scheduled Route Delivery
    • Pickup-Enabled Hybrid Delivery
  • By Medication Type
    • Chronic Disease Medication
    • Acute Disease Medication
    • Specialty Medication and Biologics
    • Others
  • By Prescription Type
    • New Prescriptions
    • Refill Prescriptions
  • By End User
    • Individual Patient
    • Healthcare Institutions
    • Home Healthcare Setting
    • Corporate and Institutional Clients
  • By Channel
    • Pharmacy-Owned Channel
    • Payer and PBM Home-Delivery Channel
    • Digital Health and E-Pharmacy Channel
    • Hospital and Health-System Channel
    • Employer and Government Program Channel
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Geography Analysis

North America held a 41.03% share of the prescription delivery services market in 2026, supported by established pharmacy benefit manager networks, large mail-order operations, and investments in same-day delivery capacity. Amazon Pharmacy plans to provide same-day prescription delivery across nearly 4,500 U.S. cities and towns in 2026, while Walmart expanded nationwide same-day delivery to refrigerated and reconstituted prescriptions in September 2025. The increased use of refrigerated GLP-1 therapies is driving demand for faster, temperature-controlled delivery. DEA requirements, state pharmacy board regulations, and pharmacy accreditation standards continue to shape the operating environment.

Asia-Pacific is forecast to grow at a 14.56% CAGR through 2032, driven by quick-commerce platforms and expanding pharmacy networks. In India, Apollo 24/7 delivered 48% of its Delhi-NCR orders within 19 minutes through more than 6,500 Apollo Pharmacy stores, covering over 19,000 pin codes. The region also depends on evolving e-prescription regulations and telepharmacy standards to support home delivery services. As providers expand beyond major urban areas, compliance requirements are becoming increasingly important in differentiating licensed platforms from informal online medicine sellers.

Germany’s mandatory electronic prescription system supports online prescription conversion, while the Gematik CardLink mechanism remains part of the prescription redemption infrastructure. In the United Kingdom, distance-selling pharmacy models continue to serve patients selecting home delivery through National Health Service prescription nominations. In Brazil, Memed reported a 70% share of digital medical prescriptions, highlighting the potential for digital prescriptions to support delivery-linked fulfillment. Middle East and Africa markets remain in the early development stage, with cold-chain limitations, uneven regulations, and limited broadband access constraining broader adoption.



List of Companies Covered in this Report:

  1. Albertsons Companies Inc.
  2. Alto Pharmacy Inc.
  3. Amazon.com
  4. API Holdings Private Limited
  5. Apollo Hospitals Enterprise Limited
  6. Capsule Corporation
  7. Chemist Warehouse Group Limited
  8. CVS Health
  9. DocMorris N.V.
  10. GoodRx Holdings Inc.
  11. NowRx Inc.
  12. Pharmacy2U Ltd
  13. Redcare Pharmacy N.V.
  14. Tata Digital Private Limited
  15. The Cigna Group
  16. The Kroger
  17. United Health Group
  18. Walgreens Boots Alliance Inc.
  19. Walmart Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Chronic-Disease Refill Density and Longer-Day-Supply Prescriptions
4.2.2 Telemedicine-to-Pharmacy Prescription Conversion
4.2.3 Pharmacy-Desert Access and Rural Travel Avoidance
4.2.4 Specialty and High-Value Medication Home Fulfillment
4.2.5 Mainstreaming of Automated Refill and Adherence Programs
4.2.6 Same-Day Delivery Infrastructure Reaching Underserved Communities
4.3 Market Restraints
4.3.1 Cold-Chain and Temperature-Excursion Liability
4.3.2 Pharmacist Counseling and Medication-Error Risk Outside the Pharmacy
4.3.3 Last-Mile Economics for Low-Density and Failed-Delivery Addresses
4.3.4 Controlled-Substance, Identity, and Signature-Verification Constraints
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Competitive Rivalry
4.7.2 Threat of New Entrants
4.7.3 Bargaining Power of Suppliers
4.7.4 Bargaining Power of Buyers
4.7.5 Threat of Substitutes
5 MARKET SIZE AND GROWTH FORECASTS (VALUE, USD)
5.1 By Service Model
5.1.1 Mail-Order Pharmacy Services
5.1.2 Retail Pharmacy Home Delivery
5.1.3 Digital Pharmacy Fulfillment
5.1.4 Hospital and Specialty Pharmacy Delivery
5.1.5 Telepharmacy-Enabled Home Dispensing
5.2 By Delivery Mode
5.2.1 Standard Postal Delivery
5.2.2 Next-Day Delivery
5.2.3 Same-Day Delivery
5.2.4 Scheduled Route Delivery
5.2.5 Pickup-Enabled Hybrid Delivery
5.3 By Medication Type
5.3.1 Chronic Disease Medication
5.3.2 Acute Disease Medication
5.3.3 Specialty Medication and Biologics
5.3.4 Others
5.4 By Prescription Type
5.4.1 New Prescriptions
5.4.2 Refill Prescriptions
5.5 By End User
5.5.1 Individual Patient
5.5.2 Healthcare Institutions
5.5.3 Home Healthcare Setting
5.5.4 Corporate and Institutional Clients
5.6 By Channel
5.6.1 Pharmacy-Owned Channel
5.6.2 Payer and PBM Home-Delivery Channel
5.6.3 Digital Health and E-Pharmacy Channel
5.6.4 Hospital and Health-System Channel
5.6.5 Employer and Government Program Channel
5.7 By Geography
5.7.1 North America
5.7.1.1 United States
5.7.1.2 Canada
5.7.1.3 Mexico
5.7.2 Europe
5.7.2.1 Germany
5.7.2.2 United Kingdom
5.7.2.3 France
5.7.2.4 Italy
5.7.2.5 Spain
5.7.2.6 Rest of Europe
5.7.3 Asia-Pacific
5.7.3.1 China
5.7.3.2 India
5.7.3.3 Japan
5.7.3.4 Australia
5.7.3.5 South Korea
5.7.3.6 Rest of Asia-Pacific
5.7.4 Middle East and Africa
5.7.4.1 GCC
5.7.4.2 South Africa
5.7.4.3 Rest of Middle East and Africa
5.7.5 South America
5.7.5.1 Brazil
5.7.5.2 Argentina
5.7.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
6.3.1 Albertsons Companies Inc.
6.3.2 Alto Pharmacy Inc.
6.3.3 Amazon.com Inc.
6.3.4 API Holdings Private Limited
6.3.5 Apollo Hospitals Enterprise Limited
6.3.6 Capsule Corporation
6.3.7 Chemist Warehouse Group Limited
6.3.8 CVS Health Corporation
6.3.9 DocMorris N.V.
6.3.10 GoodRx Holdings Inc.
6.3.11 NowRx Inc.
6.3.12 Pharmacy2U Ltd
6.3.13 Redcare Pharmacy N.V.
6.3.14 Tata Digital Private Limited
6.3.15 The Cigna Group
6.3.16 The Kroger Co.
6.3.17 UnitedHealth Group Incorporated
6.3.18 Walgreens Boots Alliance Inc.
6.3.19 Walmart Inc.
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
7.1 White-Space and Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Albertsons Companies Inc.
  • Alto Pharmacy Inc.
  • Amazon.com Inc.
  • API Holdings Private Limited
  • Apollo Hospitals Enterprise Limited
  • Capsule Corporation
  • Chemist Warehouse Group Limited
  • CVS Health Corporation
  • DocMorris N.V.
  • GoodRx Holdings Inc.
  • NowRx Inc.
  • Pharmacy2U Ltd
  • Redcare Pharmacy N.V.
  • Tata Digital Private Limited
  • The Cigna Group
  • The Kroger Co.
  • UnitedHealth Group Incorporated
  • Walgreens Boots Alliance Inc.
  • Walmart Inc.